Survival of medicare patients after enrollment in hospice programs

New England Journal of Medicine

Volumn 335, Issue 3, 1996, Pages 172-178

  Christakis, Nicholas A ^a,c   Escarce, José J ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BILE DUCT CANCER; COLORECTAL CANCER; FEMALE; HUMAN; KIDNEY FAILURE; LEUKEMIA; LIFE EXPECTANCY; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SURVIVAL; TERMINAL CARE; TERMINAL DISEASE;

CANCER; CLINICAL APPROACH/SOURCE; DEATH AND EUTHANASIA; EMPIRICAL APPROACH; FEDERAL GOVERNMENT; MEDICARE; UNITED STATES;

AGED; DEMENTIA; FEDERAL GOVERNMENT; FEMALE; HEART FAILURE, CONGESTIVE; HOSPICE CARE; HUMANS; KIDNEY FAILURE; LUNG DISEASES, OBSTRUCTIVE; MALE; MEDICARE; NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; UNITED STATES;

EID: 0030000230     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199607183350306     Document Type: Article

References (45)

1. Moinpour CM, Polissar L. Factors affecting place of death of hospice and non-hospice cancer patients. Am J Public Health 1989;79:1549-51.
2. Mor V, Hiris J. Determinants of site of death among hospice cancer patients. J Health Soc Behav 1983;24:375-85.
3. Greer DS, Mor V, Morris JN, Sherwood S, Kidder D, Birnbaum H. An alternative in terminal care: results of the National Hospice Study. J Chronic Dis 1986;39:9-26.
4. Kanc RL, Klein SJ, Bernstein L, Rothenberg R, Wales I. Hospice role in alleviating the emotional stress of terminal patients and their families. Med Care 1985;23:189-97.
5. Wallston KA, Burger C, Smith RA, Baugher RJ. Comparing the quality of death for hospice and non-hospice cancer patients. Med Care 1988;26: 177-82.
6. Dawson NJ. Need satisfaction in terminal care settings. Soc Sci Med 1991;32:83-7.
7. Mor V, Greer DS, Kastenbaum R. The hospice experiment. Baltimore: John Hopkins University Press, 1988.
8. Kidder D. The effects of hospice coverage on Medicare expenditures. Health Serv Res 1992;27:195-2 17.
9. Mor V, Kidder D. Cost savings in hospice: final results of the National Hospice Study. Health Serv Res 1985;20:407-22.
10. Hannan KL, O'Donnell JF. An evaluation of hospices in the New York State Hospice Demonstration Program. Inquiry 1984;21:338-48.
11. Spector WD, Mor V. Utilization and charges for terminal cancer patients in Rhode Island. Inquiry 1984;21:328-37.
12. Brooks CH, Smyth-Staruch K. Hospice home care cost savings to third-party insurers. Med Care 1984;22:691-703.
13. Davis FA. Medicare hospice benefit: early program experiences. Health Care Financ Rev 1988;9(4):99-111.
14. Bulkin W, Lukashok H. Rx for dying: the case for hospice. N Engl J Med 1988;318:376-8.
15. National Hospice Organization. 1992 Stats show continued growth in programs and patients. NHO Newsline 1993;3(T6):1-2.
16. Strahan GW. An overview of home health and hospice care patients: preliminary data from the 1993 National Home and Hospice Care Survey. Advance data from vital and health statistics. No. 256. Hyattsville, Md.: National Center for Health Statistics, 1994. (DHHS publication no. (PHS) 94-1250.)
17. Social Security Act 1861 (dd)(3)(A).
18. Lynn I, Teno JM, Harrell FE Jr. Accurate prognostications of death: opportunities and challenges tor clinicians. West J Med 1995;163:250-7.
19. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
20. Kaplan EL, Meier P Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
21. Tnkey JW. Exploratory data analysis. Reading, Mass.: Addison-Wesley, 1977.
22. Teachman JD, Hayward MD. Interpreting hazard rate models. Sociol Methods Res 1993;21:340-71.
23. Department of Health and Human Services. The international classification of diseases, 9th rev., clinical modification: 1CD-9-CM. Vol. I Diseases: tabular list. Washington, D.C.: Government Printing Office, 1980. (DHHS publication no. (PHS) 80-1260.)
24. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
25. Cohen J, Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences. Hillsdale, N.J.: Lawrence Erlbaum, 1975.
26. Forster LH, Lynn J. The use of physiologic measures and demographic variables to predict longevity among inpatient hospice applicants. Am J Hospice Care 1989;6:31-4.
27. Infeld DL, Crum GK, Koshuta MA. Characteristics of patients in a king-term care hospice setting. Hospice J 1990;6(4):81-104.
28. Allard P, Dionne A, Potvin D. Factors associated with length of survival among 1081 terminally ill cancer patients. J Palliat Care 1995;11(3):20-4.
29. Christakis NA. Timing of referral of terminally ill patients to an outpatient hospice. J Gen Intern Med 1994;9:314-20.
30. Schonwetter RS, Teasdale TA, Storey P, Luchi RJ. Estimation of survival time in terminal cancer patients: an impedance to hospice admissions? Hospice J 1990;6(4):65-79.
31. Rosenthal MA, Gebski VJ, Kefford RF, Stuart Harris RC. Prediction of life-expectancy in hospice patients: identification of novel prognostic-factors. Palliat Med 1993;7:199-204.
32. Evans C, McCarthy M. Referral and survival of patients accepted by a terminal care support team. J Epibemiol Community Health 1984;38:310-4.
33. Bruera E, Miller MJ, Kuehn N, MacEachern T, Hanson J. Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage 1992;7:82-6.
34. Reuben DB, Mor V, Hiris I. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 1988;148:1586-91.
35. Hyman RB, Bulkin W. Physician reported incentives and disincentives for referring patients to hospice. Hospice J 1990;6(4):39-64.
36. Office of Research and Demonstrations. Report to Congress: high-cost hospice care. Baltimore: Health Care Financing Administration, 1994. (HCFA publication no. 03360.)
37. Pearlman RA. Inaccurate predictions of life expectancy: dilemmas and opportunities. Arch Intern Med 1988;148:2537-8.
38. Brody H, Lynn J. The physician's responsibility under the new Medicare reimbursement for hospice care. N Engl J Med 1984;310:920-2.
39. Potter JF. A challenge for the hospice movement. N Engl J Med 1980; 302:53-5.
40. Forster LE, Lynn J. Predicting life span for applicants to inpatient hospice. Arch Intern Med 1988;148:2540-3.
41. Parkes CM. Accuracy of predictions of survival in later stages of cancer. BMJ 1972;2:29-31.
42. Knaus WA, Harrell FE Jr, Lynn J, et al. The SUPPORT prognostic model: objective estimates of survival for seriously ill hospitalized adults: Study to Understand Prognoses and Preferences tor Outcomes and Risks of Treatments. Ann Intern Med 1995;122:191-203.
43. Carney K, Burns N, Brobst B. Hospice costs and Medicare reimburse ment: an application of break-even analysis. Nurs Econ 1989;7:41-7.
44. Iezwini LI, Foley SM, Daley J, Hughes J, Fisher KS, Heeren T. Co-morbiditics, complications, and coding bias: does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA 1992;267:2197-203.
45. Romano PS, Mark DH. Bias in the coding of hospital discharge data and its implications for quality assessment. Med Care 1994;32:81-90.